Search results
22 sty 2016 · Transabdominal ultrasound should be the initial diagnostic test in patients with suspected cholangiocarcinoma because it can detect the presence, extent, and location of biliary obstruction; identify intrahepatic masses; and suggest other etiologies, such as choledocholithiasis or Mirizzi syndrome. 50, 51 ICCs can present as dilated ...
19 paź 2022 · Dedicated studies of adjuvant treatment for patients with resected ICC are rare and usually include patients with gallbladder cancer and other biliary tract cancers.
29 maj 2024 · Background: Intrahepatic cholangiocarcinoma (IHCC), a rare biliary tract cancer, has been rising in incidence and is associated with poor survival. With the advent of new treatment modalities and various ongoing research, population-based perspective can be helpful to reflect the progress in managing this deadly disease and provide updated ...
Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy arising from the liver. ICC makes up about 10% of all cholangiocarcinomas. It arises from the peripheral bile ducts within the liver parenchyma, proximal to the secondary ...
10 lut 2024 · High-level evidence regarding specific systemic therapies for use in resectable intrahepatic cholangiocarcinoma remains sparse, as most of the evidence is extrapolated from trials involving heterogeneous tumor populations.
17 lut 2021 · Intrahepatic cholangiocarcinoma (ICC) is a primary liver malignancy originated from intrahepatic bile duct epithelial cells, whose incidence is second only to hepatocellular carcinoma (HCC) 1.
Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules and the second-order bile ducts. It is the second most frequent primary liver cancer after hepatocellular carcinoma, and its global incidence is increasing.
